Clinical Trials on Detrusor, Overactive

Total 2057 results

Velicept Therapeutics, Inc.

Completed

Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects

Healthy Subjects, Overactive Bladder
Pfizer

Completed

A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects

Treatment of Overactive Bladder

United States
Maastricht University Medical Center

Completed

Basic Sensations Coming From the Bladder

Healthy | Overactive Bladder Syndrome

Netherlands
Walter Reed National Military Medical Center

Recruiting

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

Overactive Bladder Syndrome

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

Comparison and Evaluation of USSQ, OABSS, and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral D-J Stents in Patients Who Underwent URL

Urolithiasis | Overactive Bladder Syndrome

China
University Hospital, Ghent
Astellas Pharma Inc; Medtronic

Completed

Treatment of the Overactive Bladder Syndrome: A Delphi Study

Overactive Bladder Syndrome

Belgium
University Hospital, Ghent

Terminated

TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I) (TaPaS)

Overactive Bladder Syndrome

Belgium
Stimvia s.r.o.

Completed

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

Overactive Bladder (OAB) | Failed Any OAB Pharmacotherapy

Czechia
Astellas Scientific & Medical Affairs, Inc.

Completed

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) (PERSPECTIVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Canada
Astellas Pharma Europe Ltd.

Completed

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) (BESIDE)

Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
Chung Shan Medical University

Unknown

Efficacy of Different Electrical Stimulation Placement in Patients With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Taiwan
Far Eastern Memorial Hospital

Completed

Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

Overactive Bladder Syndrome

Taiwan
Salvat

Completed

SVT-40776 in Patients Suffering From Overactive Bladder Syndrome

Overactive Bladder (OAB)
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

United States
University Hospital, Clermont-Ferrand

Unknown

Evaluation of Professional Practices in the Treatment of Refractory Idiopathic Overactive Bladder at the Dose of 50 Units (TOX50IUU) (TOX50IUU)

Bladder, Overactive

France
Taipei Veterans General Hospital, Taiwan

Recruiting

Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial

Overactive Bladder Syndrome

Taiwan
Pamukkale University

Completed

Intravaginal Electrical Stimulation in Idiopathic Overactive Bladder

Electrical Stimulation | Idiopathic Overactive Bladder | Bladder Training

Turkey
Buddhist Tzu Chi General Hospital

Unknown

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

Overactive Bladder Syndrome

Taiwan
Radboud University Medical Center

Withdrawn

Overactive Bladder (OAB) Drink Advice Study

Overactive Bladder Syndrome

Netherlands
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
Pfizer

Completed

A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
Watson Pharmaceuticals

Completed

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Detrusor Hyperreflexia

United States
Sunovion
PPD; ICON Clinical Research; Covance; Dainippon Sumitomo Pharma America; ClinPhone...

Completed

SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)

Overactive Bladder Syndrome (OABS)

France, United Kingdom, United States, Estonia, Germany, Latvia, Lithuania, Poland, Spain
Astellas Pharma Europe Ltd.

Completed

Vesitirim™ in Men Postmarketing Observational Study (VIM)

Overactive Bladder (OAB) | Lower Urinary Tract Symptoms (LUTS)

Ireland
Hospital Italiano de Buenos Aires

Recruiting

Virtual Bladder Training for Overactive Bladder Syndrome in Women. Which Symptom Responds Better?

Overactive Bladder Syndrome

Argentina
Centre Hospitalier de Roubaix

Not yet recruiting

Effectiveness of HYPNOsis Masks During Botulinum TOXin Injections in Idiopathic Overactive Bladder(HypnoTox) (HypnoTox)

Idiopathic Overactive Bladder
Far Eastern Memorial Hospital

Recruiting

Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Taiwan
Far Eastern Memorial Hospital

Recruiting

Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing

Overactive Bladder Syndrome

Taiwan
Astellas Pharma Global Development, Inc.

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) (PILLAR)

Overactive Bladder (OAB)

United States, Canada
Maastricht University Medical Center
University Hospital, Antwerp; Zuyderland Hospital

Unknown

Experience Sampling Method in OAB Patients

Overactive Bladder | Overactive Bladder Syndrome

Netherlands
University of Sao Paulo General Hospital

Completed

Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment (OAB)

Overactive Bladder Syndrome

Brazil
Far Eastern Memorial Hospital

Withdrawn

Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Taiwan
University of Sao Paulo General Hospital

Completed

Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome

Overactive Bladder Syndrome

Brazil
Federal University of São Paulo

Unknown

Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome

Overactive Bladder Syndrome
Maastricht University Medical Center

Unknown

The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Netherlands
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder (OAB)

Japan
Astellas Pharma Europe Ltd.

Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice (BELIEVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder Overactive

Czechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
Hospital Universitário Professor Edgard Santos

Unknown

A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder

Overactive Bladder Associated With HTLV-1

Brazil
National Taiwan University Hospital

Completed

BOO and DU and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele

Bladder Outlet Obstruction and Detrusor Underactivity in Women With Severe Cystocele
University Of Perugia

Unknown

Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin

Overactive Bladder Syndrome

Italy
National Taiwan University Hospital

Completed

Predictors for Retreatement of OAB After DC Mirabegron

Recurrence of Overactive Bladder Syndrome

Taiwan
Maastricht University Medical Center

Completed

Effect of Pulse Rate Changes on Clinical Outcome

Overactive Bladder Syndrome | Chronic Urinary Retention

Netherlands
Universiteit Antwerpen

Unknown

Sacral Neuromodulation and Pudendal Somatic Afferents

Overactive Bladder, Non Obstructive Urinary Retention

Belgium
University of Zurich

Completed

Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms

Overactive Bladder Syndrome

Switzerland
Pamukkale University

Recruiting

Tibial Nerve and Extracorporeal Magnetic Stimulation for Overactive Bladder

Idiopathic Overactive Bladder | Bladder Training | Transcutaneous Tibial Nerve Stimulation | Magnetic Stimulation

Turkey
Centre Hospitalier Universitaire Dijon

Unknown

Retrospective Study of Prescribed Physical Activity in Patients With Overactive Bladder Syndrome Monitored Within the Pelvi-perineology Network in Dijon: Evaluation of Prescription Compliance and Impact on Quality of Life (HAV-AP)

iOAB= Idiopathic Overactive Bladder

France
Pfizer

Completed

This Is A Study Of Bioavailability And Food Effect For Fesoterodine.

Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency

United States
Astellas Pharma Europe B.V.

Completed

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder (SYNERGY)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

United States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
Takeda

Completed

Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome

Overactive Bladder Syndrome
Astellas Pharma Europe B.V.

Completed

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder (SYNERGY II)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

Belgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more

Clinical Trials on Detrusor, Overactive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations